We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

91 hedge funds and large institutions have $182M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more call options, than puts

Call options by funds: $1.25M | Put options by funds: $250K

300% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 8

180% more capital invested

Capital invested by funds: $64.9M → $182M (+$117M)

65% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 20

32% more funds holding

Funds holding: 69 → 91 (+22)

Holders
91
Holders Change
+22
Holders Change %
+31.88%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
33
Reduced
20
Closed
8
Calls
$1.25M
Puts
$250K
Net Calls
+$1M
Net Calls Change
+$1M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$6.15M
2
OAM
Oxford Asset Management
United Kingdom
+$3.13M
3
BA
BlackRock Advisors
Delaware
+$3.08M
4
BIT
BlackRock Institutional Trust
California
+$2.86M
5
TC
TFS Capital
Pennsylvania
+$2.74M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$11.4M
2
PI
Putnam Investments
Massachusetts
-$2.5M
3
CCM
Cadence Capital Management
Massachusetts
-$992K
4
NFA
Nationwide Fund Advisors
Ohio
-$601K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$583K
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
26
Menta Capital
California
$1.47M +$68.7K +6,500 +7%
NFA
27
Nationwide Fund Advisors
Ohio
$1.44M -$601K -56,900 -36%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.28M -$148K -13,998 -14%
ERSOT
29
Employees Retirement System of Texas
Texas
$1.24M +$919K +87,000 New
Citadel Advisors
30
Citadel Advisors
Florida
$1.24M +$425K +40,210 +86%
CCMH
31
Cornerstone Capital Management Holdings
New York
$1.07M -$266K -25,200 -25%
CS
32
Credit Suisse
Switzerland
$1.03M +$611K +57,826 +410%
CIP
33
Convergence Investment Partners
Florida
$967K +$716K +67,750 New
Charles Schwab
34
Charles Schwab
California
$911K +$214K +20,228 +47%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$909K +$459K +43,500 +216%
TCIM
36
TIAA CREF Investment Management
New York
$881K +$11.5K +1,092 +2%
Renaissance Technologies
37
Renaissance Technologies
New York
$840K +$621K +58,800 New
OAM
38
Oberweis Asset Management
Illinois
$761K +$16.9K +1,600 +3%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$747K +$334K +31,600 +208%
BIM
40
BlackRock Investment Management
Delaware
$732K -$5.52K -523 -1%
SO
41
STRS Ohio
Ohio
$727K -$432K -40,900 -45%
ARTA
42
A.R.T. Advisors
New York
$632K +$468K +44,322 New
SIM
43
Spark Investment Management
New York
$623K +$26.4K +2,500 +6%
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$554K +$410K +38,802 New
Wells Fargo
45
Wells Fargo
California
$551K +$197K +18,636 +94%
Allianz Asset Management
46
Allianz Asset Management
Germany
$548K +$405K +38,390 New
American Century Companies
47
American Century Companies
Missouri
$477K +$353K +33,389 New
ProShare Advisors
48
ProShare Advisors
Maryland
$474K +$35K +3,310 +11%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$467K +$1.48K +140 +0.4%
GC
50
Globeflex Capital
California
$426K +$623 +59 +0.2%
1
2
3 4

SCMP Hedge Fund Activity: Q4 2014 in Review

91 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q4 2014, worth a combined $182M — up 180% from $64.9M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SCMP positions and 8 closed out — a net gain of 24 holders — while 33 added to existing stakes and 20 trimmed.

The largest buyer was Millennium Management, adding an estimated $6.15M. The largest seller was Visium Asset Management, cutting an estimated $11.4M.

  • 91 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q4 2014, up from 69 in Q3 2014.
  • Funds reported $182M of Sucampo Pharmaceuticals, Inc. stock for Q4 2014, up 180% quarter-over-quarter.
  • 32 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q4 2014 and 8 closed out, a net change of +24 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q4 2014 was Millennium Management, an estimated $6.15M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q4 2014 was Visium Asset Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2014.